UNSPSC 51172707: Belladonna/methenamine/salicylamide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GU209. This VA Drug Class (GU209) classifies this compound as belonging to the group ANTISPASMODICS, URINARY, OTHER.

UNSPSC 51172707 Belladonna/methenamine/salicylamide is a Commodity code whose nominal scope—a specific combination of medicinal compounds—bears little connection to the state and local opportunities actually posted under it. Recent solicitations tagged with this code are instead asking for offender drug testing services, pharmaceutical supply agreements, and pharmacy benefit program infrastructure, none of which involve the active ingredients the code names. The code shows no relevant recent activity aligned with its stated pharmaceutical composition.

Collin County Community Supervision and Corrections Department issued RFP 2026-327 on July 9, 2026 for offender specimen collection and drug testing services with a proposal deadline of July 23, 2026, estimated contract value of $600,000, and a two-year initial term with optional one-year renewals not to exceed five years. The Texas Health and Human Services Commission posted RFI HHS0017013 in March 2026 to gather market intelligence on direct-to-manufacturer prescription programs for state employee and retiree plans. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 on January 20, 2026 for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The mismatch between the code's pharmaceutical specificity and the breadth of pharmaceutical and health services procurement represented in these opportunities suggests either a data-entry error in the state and local databases or an overly narrow code assignment to substantially different health procurement activity.